Your browser doesn't support javascript.
loading
SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
Hall, Ross; Guedán, Anabel; Yap, Melvyn W; Young, George R; Harvey, Ruth; Stoye, Jonathan P; Bishop, Kate N.
Afiliação
  • Hall R; Retroviral Replication Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Guedán A; Retroviral Replication Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Yap MW; Retroviral Replication Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Young GR; Bioinformatics and Biostatistics STP, The Francis Crick Institute, London, United Kingdom.
  • Harvey R; World Influenza Centre, The Francis Crick Institute, London, United Kingdom.
  • Stoye JP; Retrovirus-Host Interactions Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Bishop KN; Department of Infectious Disease, Imperial College London, United Kingdom.
PLoS Pathog ; 18(8): e1010349, 2022 08.
Article em En | MEDLINE | ID: mdl-36007063
SARS-CoV-2 is a betacoronavirus and the etiological agent of COVID-19, a devastating infectious disease. Due to its far-reaching effect on human health, there is an urgent and growing need to understand the viral molecular biology of SARS-CoV-2 and its interaction with the host cell. SARS-CoV-2 encodes 9 predicted accessory proteins, which are presumed to be dispensable for in vitro replication, most likely having a role in modulating the host cell environment to aid viral replication. Here we show that the ORF6 accessory protein interacts with cellular Rae1 to inhibit cellular protein production by blocking mRNA export. We utilised cell fractionation coupled with mRNAseq to explore which cellular mRNA species are affected by ORF6 expression and show that ORF6 can inhibit the export of many mRNA including those encoding antiviral factors such as IRF1 and RIG-I. We also show that export of these mRNA is blocked in the context of SARS-CoV-2 infection. Together, our studies identify a novel mechanism by which SARS-CoV-2 can manipulate the host cell environment to supress antiviral responses, providing further understanding to the replication strategies of a virus that has caused an unprecedented global health crisis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Virais / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Virais / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido